Related Experiment Video

Updated: May 9, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

MicroRNAs: new insights into chronic childhood diseases

Ahmed Omran1, Dalia Elimam, Fei Yin

  • 1Department of Pediatrics and Neonatology, Suez Canal University, Ismailia 41522, Egypt.

Biomed Research International
|July 24, 2013
PubMed

Insights

MicroRNAs (miRNAs) are implicated in pediatric chronic diseases like asthma, diabetes, epilepsy, and cystic fibrosis. Understanding miRNA roles may lead to new therapies for normal development and disability prevention in children.

Area of Science:

  • Pediatric chronic non-neoplastic diseases
  • Molecular biology
  • Biomedical research

Background:

  • Chronic diseases are a leading cause of childhood morbidity and mortality globally.
  • Pediatric chronic illnesses negatively impact development, education, and increase health risks.
  • Understanding disease pathogenesis is crucial for effective intervention.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in major pediatric chronic diseases.
  • To highlight the potential of miRNA-based research for novel therapeutic strategies.
  • To support normal development and prevent disabilities in affected children.

Main Methods:

  • Literature review focusing on microRNA involvement in pediatric chronic diseases.
  • Analysis of recent studies linking miRNAs to asthma, diabetes, epilepsy, and cystic fibrosis.
  • Synthesis of current knowledge on miRNA functions in these conditions.

Main Results:

  • MicroRNAs are significantly involved in the pathogenesis of major pediatric chronic non-neoplastic diseases.
  • Specific miRNAs show potential as biomarkers and therapeutic targets.
  • Evidence suggests miRNAs regulate key pathways in asthma, diabetes, epilepsy, and cystic fibrosis.

Conclusions:

  • MicroRNA research offers promising avenues for novel treatments in pediatric chronic diseases.
  • Targeting miRNAs could improve developmental outcomes and reduce long-term complications.
  • Further investigation into miRNA-based therapies is essential for pediatric health.

More Related Videos

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...